ReviewCancers2025

The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.

Larisa Maria Badau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.